# 60 Degrees Pharmaceuticals, Inc.: filings

SXTP · Nasdaq · CIK 1946563 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sxtp.md) · [Financials](/companies/sxtp/financials.md) · [Filings](/companies/sxtp/filings.md) · [Insiders](/companies/sxtp/insiders.md)

## Reports and events: 75 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 48, 4 27, CORRESP 26, 3 13, UPLOAD 13, 10-Q 10, 424B5 10, SCHEDULE 13G/A 9, SCHEDULE 13G 8, EFFECT 7, S-1/A 6, DEF 14A 4, PRE 14A 4, S-1 4, 10-K 3, 424B4 3, D 3, DRS 3, S-3 3, 8-A12B/A 2, DRS/A 2, DRSLTR 2, SC 13G 2, SC 13G/A 2, SEC STAFF LETTER 2, 8-A12B 1, CERT 1, DEFR14A 1, DEL AM 1, NT 10-Q 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 08:00 ET | [8-K](/filings/0001213900-26-111864.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-111864 |
| 2026-10-06 | 07:45 ET | [8-K](/filings/0001213900-26-106979.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-106979 |
| 2026-09-14 | 16:06 ET | [8-K](/filings/0001213900-26-099702.md) | 8.01 Other events | 0001213900-26-099702 |
| 2026-09-08 | 16:27 ET | [8-K](/filings/0001213900-26-098056.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-098056 |
| 2026-08-14 | 15:34 ET | [10-Q](/filings/0001554855-26-001860.md) | Quarterly report, period 2026-06-30 | 0001554855-26-001860 |
| 2026-08-06 | 16:07 ET | [8-K](/filings/0001213900-26-086136.md) | 5.07 Shareholder vote results | 0001213900-26-086136 |
| 2026-08-04 | 16:44 ET | [8-K](/filings/0001213900-26-085235.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-085235 |
| 2026-07-20 | 16:05 ET | [8-K](/filings/0001213900-26-079612.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-079612 |
| 2026-07-09 | 16:05 ET | [8-K](/filings/0001213900-26-076715.md) | 8.01 Other events | 0001213900-26-076715 |
| 2026-07-02 | 16:05 ET | [DEF 14A](/filings/0001213900-26-074961.md) | Proxy statement, period 2026-08-05 | 0001213900-26-074961 |
| 2026-06-03 | 16:57 ET | [8-K](/filings/0001213900-26-064796.md) | 8.01 Other events | 0001213900-26-064796 |
| 2026-05-18 | 16:33 ET | [8-K](/filings/0001213900-26-058495.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-058495 |
| 2026-05-15 | 08:11 ET | [10-Q](/filings/0001554855-26-001058.md) | Quarterly report, period 2026-03-31 | 0001554855-26-001058 |
| 2026-03-30 | 17:29 ET | [10-K](/filings/0001554855-26-000467.md) | Annual report, period 2025-12-31 | 0001554855-26-000467 |
| 2026-03-20 | 16:15 ET | [8-K](/filings/0001213900-26-032352.md) | 8.01 Other events | 0001213900-26-032352 |
| 2026-03-13 | 17:15 ET | [8-K](/filings/0001213900-26-027756.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-027756 |
| 2026-03-12 | 16:36 ET | [8-K](/filings/0001213900-26-027008.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-027008 |
| 2026-02-12 | 08:58 ET | [8-K](/filings/0001213900-26-015239.md) | 8.01 Other events | 0001213900-26-015239 |
| 2026-01-23 | 17:20 ET | [8-K](/filings/0001213900-26-007330.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure | 0001213900-26-007330 |
| 2026-01-21 | 16:05 ET | [8-K](/filings/0001213900-26-006179.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-006179 |
| 2026-01-08 | 09:00 ET | [8-K](/filings/0001213900-26-002359.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-002359 |
| 2025-11-13 | 13:31 ET | [10-Q](/filings/0001554855-25-002032.md) | Quarterly report, period 2025-09-30 | 0001554855-25-002032 |
| 2025-10-10 | 16:15 ET | [8-K](/filings/0001213900-25-098131.md) | 5.07 Shareholder vote results | 0001213900-25-098131 |
| 2025-09-09 | 08:00 ET | [8-K](/filings/0001213900-25-085853.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-085853 |
| 2025-09-05 | 16:20 ET | [8-K](/filings/0001213900-25-085040.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-085040 |
| 2025-08-27 | 19:17 ET | [DEF 14A](/filings/0001213900-25-080878.md) | Proxy statement, period 2025-10-08 | 0001213900-25-080878 |
| 2025-08-13 | 14:45 ET | [10-Q](/filings/0001554855-25-001009.md) | Quarterly report, period 2025-06-30 | 0001554855-25-001009 |
| 2025-07-18 | 16:57 ET | [8-K](/filings/0001213900-25-065718.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-065718 |
| 2025-07-07 | 17:23 ET | [S-1](/filings/0001213900-25-061842.md) | Registration statement | 0001213900-25-061842 |
| 2025-05-15 | 10:07 ET | [10-Q](/filings/0001213900-25-043779.md) | Quarterly report, period 2025-03-31 | 0001213900-25-043779 |
| 2025-04-09 | 08:31 ET | [8-K](/filings/0001213900-25-030102.md) | 8.01 Other events | 0001213900-25-030102 |
| 2025-03-27 | 16:06 ET | [S-1/A](/filings/0001013762-25-003353.md) | Registration statement, amended | 0001013762-25-003353 |
| 2025-03-27 | 16:01 ET | [10-K](/filings/0001013762-25-003343.md) | Annual report, period 2024-12-31 | 0001013762-25-003343 |
| 2025-02-14 | 16:37 ET | [S-1](/filings/0001213900-25-014334.md) | Registration statement | 0001213900-25-014334 |
| 2025-02-06 | 16:41 ET | [8-K](/filings/0001213900-25-010962.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-010962 |
| 2025-01-30 | 17:30 ET | [8-K](/filings/0001213900-25-008463.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-008463 |
| 2025-01-28 | 16:05 ET | [8-K](/filings/0001213900-25-007529.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-007529 |
| 2025-01-08 | 16:05 ET | [8-K](/filings/0001213900-25-002070.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-002070 |
| 2024-11-14 | 13:44 ET | [10-Q](/filings/0001213900-24-098195.md) | Quarterly report, period 2024-09-30 | 0001213900-24-098195 |
| 2024-11-06 | 17:26 ET | [8-K](/filings/0001213900-24-095068.md) | 5.07 Shareholder vote results | 0001213900-24-095068 |
| 2024-10-15 | 15:46 ET | [DEF 14A](/filings/0001213900-24-087749.md) | Proxy statement, period 2024-11-06 | 0001213900-24-087749 |
| 2024-10-08 | 08:17 ET | [8-K](/filings/0001213900-24-086079.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-086079 |
| 2024-09-06 | 16:10 ET | [8-K](/filings/0001213900-24-076515.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-076515 |
| 2024-08-28 | 15:59 ET | [8-K](/filings/0001213900-24-073351.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-073351 |
| 2024-08-14 | 15:55 ET | [8-K](/filings/0001213900-24-068942.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-068942 |
| 2024-08-14 | 10:29 ET | [10-Q](/filings/0001213900-24-068673.md) | Quarterly report, period 2024-06-30 | 0001213900-24-068673 |
| 2024-08-12 | 12:03 ET | [8-K](/filings/0001213900-24-067535.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-067535 |
| 2024-07-26 | 16:15 ET | [8-K](/filings/0001013762-24-001604.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001013762-24-001604 |
| 2024-07-16 | 17:28 ET | [8-K](/filings/0001213900-24-061853.md) | 5.07 Shareholder vote results | 0001213900-24-061853 |
| 2024-07-09 | 15:37 ET | [8-K](/filings/0001213900-24-060093.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-060093 |

Page 1 of 2. [Older](/companies/sxtp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 08:06 ET. No prices; not investment advice.